Clinical Trial Update: A Study to Investigate the Efficacy and Safety of SAR444336 in Adults With Microscopic Colitis in Clinical Remission [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the efficacy and safety of SAR444336 in adults with microscopic colitis in clinical remission is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Microscopic Colitis

Drugs mentioned

• SAR444336

Snippet

Sponsor: Sanofi | Conditions: Microscopic Colitis | Phase 2 | Status: RECRUITING